PharmaCyte Biotech, Inc. is a biotechnology firm dedicated to the development and commercialization of advanced cellular therapies within the United States.
52W Range
2ndpctl
Volume
0.27×avg
Market Cap
5.22MUSD
P/E Ratio
-0.2TTM
Div Yield
-ann
Loading chart data...
Current StateState loading
PharmaCyte Biotech, Inc.
PMCBNASDAQ Capital Market·USD·Closed
PharmaCyte Biotech, Inc.
PMCBNASDAQ·USD·Closed
$0.49
−0.98%
$0.49
−$0.00 (0.98%)
52W Range
2ndpctl
Volume
0.27×avg
Mkt Cap
5.22MUSD
P/E
-0.2TTM
Div Yield
–ann
PMCB: PharmaCyte Biotech, Inc. Stock Analysis | finqOS
